… An important finding of this systematic review is the safety of cardiac resynchronization therapy
and its tolerability in patients with advanced heart failure. Peri-implantation mortality rates …

… and worsening heart failure seen in this study are encouraging. Large-scale, controlled trials
to evaluate the effects of cardiac resynchronization on the natural history of heart failure are …

… , patients with NYHA class II or III heart failure were enrolled in the study. After clinical-trial
data suggested a mortality benefit for CRT in patients with NYHA class III heart failure … patients …

… optimal medical therapy plus cardiac resynchronization (without an ICD) in 800 patients with
NYHA class III or IV systolic heart failure and ventricular dyssynchrony determined by either …

… cardiac resynchronization is an effective therapy for patients with left ventricular systolic
dysfunction and cardiac dyssynchrony who have moderate or severe heart failure and who are …

… All the patients in our study met the guideline indications … CRT–ICD therapy decreases the
risk of heart-failure events in vulnerable patients with ischemic or nonischemic heart disease …

… CRT-D. This study, in contrast to ours, also enrolled patients with symptoms of more advanced
heart failure (… the RAFT data to patients with only mild heart-failure symptoms (NYHA class …

… in Heart Failure (CARE-HF) study. In addition, we … cardiac resynchronization and which
patient characteristics were associated with an increased risk for AF. If cardiac resynchronization …

… Cardiac resynchronization therapy (CRT) has been noted to improve symptoms and LV
systolic function and reduce mortality and hospitalizations among patients with moderate to …

… heart failure patients have severe persistent symptoms and a poor quality of life. Cardiac
resynchronization therapy (CRT), an … , improves ventricular conduction delay and left ventricular …